Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Sertraline Heart Study
ACTRN12606000329561Phase 4Terminated
- Sponsor
- Mood Research Foundation
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cardiac disease, anxiety disorder and major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoint: Reduction in anxiety. Started Jan 2006; status: terminated.
02
Drugs
sertraline
03
Conditions
cardiac diseaseanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12606000329561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000329561.